On November 4, 2022 BeiGene (NASDAQ: BGNE; HKEX: 06160; SSE: 688235), a global biotechnology company, reported that the Company will participate in two upcoming investor conferences (Press release, BeiGene, NOV 4, 2022, View Source/news-details/?id=92203083-0f98-430e-9653-a52d9d62fbea" target="_blank" title="View Source/news-details/?id=92203083-0f98-430e-9653-a52d9d62fbea" rel="nofollow">View Source [SID1234623113]):

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

The 6th Annual Cowen IO Next Virtual Conference on Friday, November 11, at 9:40 a.m. (ET); and
The 13th Annual Jefferies Global Healthcare Conference in London on Wednesday, November 16 at 11:25 a.m. (ET).
A live webcast can be accessed from the investors section of BeiGene’s websites at View Source, View Source and View Source An archived replay will be available for 90 days following the event.